Cargando…
Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910568/ https://www.ncbi.nlm.nih.gov/pubmed/29678201 http://dx.doi.org/10.1186/s13054-018-2024-y |
| _version_ | 1783316077013368832 |
|---|---|
| author | Barbosa Evora, Paulo Roberto |
| author_facet | Barbosa Evora, Paulo Roberto |
| author_sort | Barbosa Evora, Paulo Roberto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5910568 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59105682018-05-02 Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment Barbosa Evora, Paulo Roberto Crit Care Letter BioMed Central 2018-04-20 /pmc/articles/PMC5910568/ /pubmed/29678201 http://dx.doi.org/10.1186/s13054-018-2024-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter Barbosa Evora, Paulo Roberto Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment |
| title | Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment |
| title_full | Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment |
| title_fullStr | Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment |
| title_full_unstemmed | Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment |
| title_short | Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment |
| title_sort | blocking soluble guanylate cyclase could be the present and future of no/cgmp inhibition for vasoplegia treatment |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910568/ https://www.ncbi.nlm.nih.gov/pubmed/29678201 http://dx.doi.org/10.1186/s13054-018-2024-y |
| work_keys_str_mv | AT barbosaevorapauloroberto blockingsolubleguanylatecyclasecouldbethepresentandfutureofnocgmpinhibitionforvasoplegiatreatment |